Split History
ETFs Holding GNCA »    GNCA Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Genocea Biosciences is a biopharmaceutical company that discovers and develops cancer immunotherapies using its ATLAS™ platform. The ATLAS platform profiles each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by sequencing of that patient's tumor. Co.'s GEN-011 program is an adoptive T cell therapy using neoantigen-targeted peripheral cells (NPTs). The GEN-011 NPTs are specific for ATLAS identified anti-tumor antigens that are used to manufacture peripheral blood-derived, tumor-specific T cell therapy. Co.'s GEN-009 program is a neoantigen vaccine delivering adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. According to our GNCA split history records, GNCA has had 1 split.
GNCA split history picture
GNCA (GNCA) has 1 split in our GNCA split history database. The split for GNCA took place on May 22, 2019. This was a 1 for 8 reverse split, meaning for each 8 shares of GNCA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split.

When a company such as GNCA conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the GNCA split history from start to finish, an original position size of 1000 shares would have turned into 125 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into GNCA shares, starting with a $10,000 purchase of GNCA, presented on a split-history-adjusted basis factoring in the complete GNCA split history. GNCA split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/24/2014
End date: 06/02/2022
Start price/share: $142.16
End price/share: $0.05
Dividends collected/share: $0.00
Total return: -99.96%
Average Annual Total Return: -63.54%
Starting investment: $10,000.00
Ending investment: $3.59
Years: 7.86
Date Ratio
05/22/20191 for 8
GNCA is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

GNVC Split History
GRFS Split History
GSK Split History
GTS Split History
GTXI Split History
HAE Split History
HBIO Split History
HCA Split History
HEB Split History
HH Split History

Also explore: GNCA shares outstanding history

Email EnvelopeFree GNCA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

INNOVATE Corp. (VATE)
Nauticus Robotics, Inc. (KITT)
Benson Hill, Inc. (BHIL)
Scorpius Holdings, Inc (SCPX)
Senti Biosciences, Inc. (SNTI)
Catheter Precision, Inc. (VTAK)
SITE Centers Corp. (SITC)
MGO Global Inc. (MGOL)
Deckers Brands (DECK)
Alzamend Neuro, Inc. (ALZN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

GNCA Insider Buying

GNCA Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.